| Code | Description | Claims | Beneficiaries | Total Paid |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
546 |
222 |
$35K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
996 |
983 |
$30K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,117 |
769 |
$24K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
51 |
39 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,836 |
3,359 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,046 |
1,746 |
$7K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
95 |
37 |
$7K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
188 |
91 |
$4K |
| 96367 |
|
262 |
160 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
93 |
93 |
$3K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
354 |
296 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
432 |
293 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
3,247 |
2,662 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
104 |
91 |
$404.15 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
398 |
331 |
$261.56 |
| 96401 |
|
22 |
13 |
$152.54 |
| 80053 |
Comprehensive metabolic panel |
755 |
666 |
$16.74 |
| 82728 |
|
168 |
164 |
$0.00 |
| 83550 |
|
151 |
149 |
$0.00 |
| 82746 |
|
106 |
103 |
$0.00 |
| 82607 |
|
121 |
118 |
$0.00 |
| 83540 |
|
154 |
151 |
$0.00 |
| 84100 |
|
93 |
91 |
$0.00 |